BOQI ENV: Establishment of a Strategic Committee
BOQI ENV announced the establishment of a strategic committee, effective from March 28, 2025. The committee aims to enhance the company's core competitiveness, formulate strategic planning and investment strategies, and oversee implementation. The committee members include three executive directors and one independent non-executive director, with Mr. Zeng Zhijun serving as the chairman. In addition, there have been changes to the board members to comply with the corporate governance code of the Hong Kong Stock Exchange
According to the announcement from BOQI ENV (02377), on March 28, 2025, in order to meet the strategic development needs of the company, enhance the company's core competitiveness, determine the company's development plan, improve the investment decision-making process, strengthen scientific decision-making, and improve the quality and effectiveness of major investment decisions, as well as to 完善 the company's corporate governance structure, the board of directors resolved to establish a strategic committee of the board, effective from March 28, 2025. The strategic committee is responsible for (including) formulating the company's strategic planning and investment strategies, supervising their implementation, and reporting to the board of directors. The members of the strategic committee include three executive directors (Mr. Zeng Zhijun, Mr. Liu Genyu, and Ms. Qian Xiaoning) and one independent non-executive director (Dr. Xie Guozhong), with Mr. Zeng Zhijun serving as the chairman.
There are changes to the members of the board committee, effective from March 28, 2025, in response to the revised corporate governance code set out in Appendix C1 of the Securities Listing Rules of The Stock Exchange of Hong Kong Limited, which will take effect on July 1, 2025: (i) Ms. Zhang Fan will no longer serve as a member of the audit committee of the board and has been appointed as a member of the nomination committee of the board. After Ms. Zhang Fan's appointment, the nomination committee will have one director of a different gender. (ii) Mr. Li Tao will no longer serve as a member of the nomination committee and has been appointed as a member of the audit committee.
Dr. Xie Guozhong has been designated as the Chief Independent Non-Executive Director, effective from March 28, 2025. The Chief Independent Non-Executive Director is not an executive position of the company and does not assume any management duties of the company. After the above appointments, Dr. Xie Guozhong will continue to serve as an independent non-executive director, chairman of the audit committee, member of the nomination committee, and a new member of the strategic committee
